Essential Calcitonin Monoclonal Antibody Full Package [rHWeCPOD]

Essential Calcitonin Monoclonal Antibody Full Package [rHWeCPOD]: A Precise Tool for Medical Diagnostics

The Essential Calcitonin Monoclonal Antibody Full Package [rHWeCPOD] is a cutting-edge diagnostic tool designed to assist healthcare professionals in identifying and distinguishing thyroid conditions. This antibody offers a highly specific reactivity with human calcitonin, enabling accurate labeling of thyroid C cells and medullary thyroid cancer. With its exceptional sensitivity and specificity, the Essential Calcitonin Monoclonal Antibody Full Package [rHWeCPOD] is a valuable asset in the diagnostic toolkit, providing reliable results that can lead to timely and effective treatment decisions.

Product Specifications and Benefits

Crafted with precision, the Essential Calcitonin Monoclonal Antibody Full Package [rHWeCPOD] is derived from mouse host cells, ensuring optimal performance and reliability. This antibody is highly reactive to human calcitonin, making it ideal for use in Immunohistochemistry (IHC-P) applications. Its cellular localization is within the cytoplasm, and it is particularly effective in identifying medullary thyroid carcinoma, which is characterized by its tissue specificity in medullary thyroid cancer. The antibody comes with a convenient storage solution, requiring storage at -20°C to maintain its integrity. With a shelf life of 12 months, the Essential Calcitonin Monoclonal Antibody Full Package [rHWeCPOD] provides peace of mind for researchers and healthcare professionals alike.

Applications and Target Audience

The Essential Calcitonin Monoclonal Antibody Full Package [rHWeCPOD] is a versatile tool with numerous applications in the field of medical diagnostics. It is particularly useful in distinguishing medullary thyroid cancer from other types of thyroid cancer, such as papillary and follicular thyroid cancer, thanks to its ability to react with calcitonin. This antibody is an essential tool for oncologists, pathologists, and researchers who specialize in thyroid diseases. By offering a clear and precise distinction between different thyroid conditions, the Essential Calcitonin Monoclonal Antibody Full Package [rHWeCPOD] helps to improve patient outcomes and advance the field of thyroid cancer research.